Dr Matthew E Falagas MD a b c , Drosos E Karageorgopoulos MD a. The Lancet, Volume 375, Issue 9710, Pages 248 - 251, 16 January 2010
Advances in molecular biology have given rise to the disciplines of pharmacogenomics and pharmacoproteomics and have created the appealing possibility of individual patient-tailored drug therapy. 1

The consideration of body size characteristics of patients is essential for the optimisation of drug therapy in specialties such as oncology, haematology, anaesthetics, critical care, and paediatrics. However, for most widely used antimicrobial agents, dosing recommendations in adults do not take into a ...

Weblink here